IL6 and Alzheimer disease: Collectively, these findings showed a novel molecular mechanism in which H3K18la/NFκB axis modulates inflammation associated with aging (infammageing) by regulating SASP components IL-6 and IL-8, promoting brain aging and AD pathological phenotypes (Fig. 8).These results present potential targets for the development of drug interventions for brain aging and AD pathology.